Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
29
|
| pubmed:dateCreated |
1988-10-26
|
| pubmed:commentsCorrections | |
| pubmed:language |
fre
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0755-4982
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
17
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1494
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:2971200-Adult,
pubmed-meshheading:2971200-Aged,
pubmed-meshheading:2971200-Humans,
pubmed-meshheading:2971200-Hydroxyurea,
pubmed-meshheading:2971200-Interferon Type I,
pubmed-meshheading:2971200-Leukemia, Myeloid,
pubmed-meshheading:2971200-Middle Aged,
pubmed-meshheading:2971200-Recombinant Proteins
|
| pubmed:articleTitle |
[Treatment of chronic myeloid leukemia by recombinant alpha interferon and hydroxyurea].
|
| pubmed:publicationType |
Letter,
Research Support, Non-U.S. Gov't
|